Terms: = Skin cancer AND KIAA1549, ENSG00000122778, 57670
4 results:
1. Expansion of the clinical and molecular spectrum of an XPD-related disorder linked to biallelic mutations in ERCC2 gene.
Agolini E; Botta E; Lodi M; Digilio MC; Rinelli M; Bellacchio E; Alesi V; Nardo T; Zambruno G; Orioli D; Alessi I; Boccuto L; Rossi S; Carai A; Colafati GS; Cacchione A; Dallapiccola B; Novelli A; Mastronuzzi A
Clin Genet; 2021 Jun; 99(6):842-848. PubMed ID: 33733458
[TBL] [Abstract] [Full Text] [Related]
2. S100/CD34-Positive Spindle Cell Mesenchymal Neoplasm Harboring kiaa1549-BRAF Fusion.
Paton DJW; Wong D; Amanuel B; Cheah K; Ardakani NM
Am J Dermatopathol; 2021 Mar; 43(3):217-220. PubMed ID: 33464748
[TBL] [Abstract] [Full Text] [Related]
3. Response to trametinib treatment in progressive pediatric low-grade glioma patients.
Selt F; van Tilburg CM; Bison B; Sievers P; Harting I; Ecker J; Pajtler KW; Sahm F; Bahr A; Simon M; Jones DTW; Well L; Mautner VF; Capper D; Hernáiz Driever P; Gnekow A; Pfister SM; Witt O; Milde T
J Neurooncol; 2020 Sep; 149(3):499-510. PubMed ID: 33026636
[TBL] [Abstract] [Full Text] [Related]
4. Trametinib for progressive pediatric low-grade gliomas.
Kondyli M; Larouche V; Saint-Martin C; Ellezam B; Pouliot L; Sinnett D; Legault G; Crevier L; Weil A; Farmer JP; Jabado N; Perreault S
J Neurooncol; 2018 Nov; 140(2):435-444. PubMed ID: 30097824
[TBL] [Abstract] [Full Text] [Related]
